Provention Bio, Inc. Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018
Revenues
Product
Collaboration Revenues
Total revenues
Operating expenses:
Cost of product revenues (excluding amortization of intangible assets)
Research and development
Selling, general and administrative
Amortization of intangible assets
Total operating expenses
Loss from operations
Interest income, net
Change in fair value of warrant liability
Interest expense
Loss before income tax benefit
Income tax benefit
Accretion on Series A Convertible Redeemable Preferred Stock
Net loss attributable to common stockholders
Net loss
Net loss per common share, basic and diluted
Weighted average common shares outstanding, basic and diluted
Other comprehensive loss:
Unrealized loss on marketable securities
Total comprehensive loss

Comments